RNA expression-based hypoxia score as a prognostic and predictive biomarker in hepatocellular carcinoma HCC | Caris Life Sciences
Home / Research / Publications / RNA expression-based hypoxia score as a prognostic and predictive biomarker in hepatocellular carcinoma HCC

Publications

RNA expression-based hypoxia score as a prognostic and predictive biomarker in hepatocellular carcinoma HCC

Background

  • Hepatocellular carcinoma (HCC) has rising incidence and mortality rates.
  • Tumor hypoxia is important in HCC pathogenesis but has not been effectively translated into practice.
  • We studied whether an RNA expression-based hypoxia score (HS) can serve as a prognostic and predictive biomarker in HCC.
Download Publication
Learn More
Name(Required)